Commodore Capital LP Q1 2021 Filing
Filed May 17, 2021
Portfolio Value
$254.0B
Holdings
31
Report Date
Q1 2021
Filing Type
13F-HR
All Holdings (31 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ACRSACLARIS THERAPEUTICS INC | 1,028,084 | $25.9B | 10.20% | |
| 2 | CCCCC4 THERAPEUTICS INC | 481,094 | $17.8B | 7.00% | |
| 3 | KURAKURA ONCOLOGY INC | 521,555 | $14.7B | 5.80% | |
| 4 | —SATSUMA PHARMACEUTICALS INC | 2,431,705 | $14.4B | 5.66% | |
| 5 | —FIVE PRIME THERAPEUTICS INC | 361,344 | $13.6B | 5.36% | |
| 6 | CBAYUSDCYMABAY THERAPEUTICS INC | 2,983,513 | $13.5B | 5.33% | |
| 7 | COGTUNUM THERAPEUTICS INC | 1,269,195 | $11.1B | 4.39% | |
| 8 | OPHTEURIVERIC BIO INC | 1,729,041 | $10.7B | 4.21% | |
| 9 | PTGXPROTAGONIST THERAPEUTICS INC | 349,600 | $9.1B | 3.56% | |
| 10 | KRON1USDKRONOS BIO INC | 298,839 | $8.7B | 3.44% | |
| 11 | —CONSTELLATION PHARMCETICLS I | 368,448 | $8.6B | 3.39% | |
| 12 | TREURTRILLIUM THERAPEUTICS INC | 795,868 | $8.5B | 3.36% | |
| 13 | VTGNUSDVISTAGEN THERAPEUTICS INC | 3,729,694 | $7.9B | 3.13% | |
| 14 | GNCAQGENOCEA BIOSCIENCES INC | 2,871,624 | $7.8B | 3.06% | |
| 15 | TCE2CELLDEX THERAPEUTICS INC NEW | 369,951 | $7.6B | 3.00% | |
| 16 | —MERSANA THERAPEUTICS INC | 429,228 | $6.9B | 2.73% | |
| 17 | MREOMEREO BIOPHARMA GROUP PLC | 2,048,757 | $6.9B | 2.72% | |
| 18 | DYNDYNE THERAPEUTICS INC | 430,112 | $6.7B | 2.63% | |
| 19 | VRDNVIRIDIAN THERAPEUTICS INC | 365,790 | $6.1B | 2.41% | |
| 20 | RLMDRELMADA THERAPEUTICS INC | 161,565 | $5.7B | 2.24% | |
| 21 | KALVKALVISTA PHARMACEUTICALS INC | 214,467 | $5.5B | 2.17% | |
| 22 | XENEXENON PHARMACEUTICALS INC | 301,392 | $5.4B | 2.12% | |
| 23 | SNDXSYNDAX PHARMACEUTICALS INC | 236,500 | $5.3B | 2.08% | |
| 24 | EPIEURESSA PHARMA INC | 176,821 | $5.1B | 2.02% | |
| 25 | SPRYSILVERBACK THERAPEUTICS INC | 97,143 | $4.2B | 1.67% | |
| 26 | PMVPPMV PHARMACEUTICALS INC | 125,000 | $4.1B | 1.62% | |
| 27 | IVAINVENTIVA SA | 262,658 | $3.9B | 1.52% | |
| 28 | MCRB1EURSERES THERAPEUTICS INC | 141,303 | $2.9B | 1.15% | |
| 29 | —BCLS ACQUISITION CORP | 250,000 | $2.6B | 1.04% | |
| 30 | MGNXMACROGENICS INC | 46,630 | $1.5B | 0.58% | |
| 31 | —LIFESCI ACQUISITION II CORP | 100,000 | $1.0B | 0.40% |